Patients with advanced urothelial carcinoma had prolonged survival with Bavencio and BSC treatment, regardless of diabetes ...
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...
Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...
Demographic disparities were observed in survival trends of patients with esophageal squamous cell carcinoma, with male sex and non-Hispanic Black race associated with increased risk of mortality. The ...
Backgrounds: Trimodal therapy (neoadjuvant chemoradiotherapy followed by esophagectomy) for locally advanced esophageal squamous cell carcinoma (ESCC ... to evaluate the prognostic value of TRG for ...
RATIONALE-306 trial focused on OS as the primary endpoint, with secondary endpoints including progression-free survival and overall response rate. Early and late responders with esophageal squamous ...
They may use markers such as thyroid transcription factor 1, napsin A, p40, p63, and cytokeratin 5/6 to help differentiate between adenocarcinoma and squamous cell carcinoma. Doctors may also use ...
Roche’s freshly approved PI3K inhibitor Itovebi can help extend the lives of certain patients with breast cancer when used ... and clinically meaningful overall survival benefit compared with ...
Preliminary phase 1/1b dose expansion results of the bifunctional EGFR/TGFβ inhibitor ficerafusp alfa (BCA101) with pembrolizumab in patients with squamous cell carcinoma of the anal canal. This is an ...
A novel treatment approach combining neoadjuvant immunotherapy with chemoradiation showed promising results in patients with locally advanced esophageal squamous cell carcinoma (ESCC), according ...
Lobectomy for stage 1A NSCLC offered the highest survival rates, with a five-year overall survival (OS ... includes a majority of lung cancer and esophageal cancer surgeries performed in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results